Senior Counsel, Corporate, Securities & Transactions

Allogene Therapeutics•South San Francisco, CA

3d•Hybrid

About The Position

Allogene Therapeutics, headquartered in South San Francisco, is a clinical-stage biotechnology company focused on developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer and autoimmune disease. The company aims to provide readily available, scalable, and reliable cell therapy solutions. The Senior Counsel, Corporate, Securities & Transactions will report to the General Counsel and play a key role in the company's public company corporate legal functions. This includes SEC reporting, corporate governance, Board and committee matters, proxy and annual meeting processes, Section 16 reporting, and related disclosure and compliance. The role will also provide support for strategic transactions, business development, M&A, licensing, collaborations, and the negotiation of various agreements. This is a hybrid position based at the South San Francisco headquarters.

Requirements

J.D. from an accredited law school and membership in good standing in at least one U.S. state bar.
California bar admission or eligibility to register as California in-house counsel required.
At least 8 years of relevant corporate/securities experience, preferably including significant experience at a nationally recognized law firm and/or in-house public company legal department.
Significant experience advising public companies on SEC reporting, corporate governance, proxy statements, annual meetings, Section 16 reporting and related disclosure matters.
Experience with Board and committee support, corporate governance policies, Nasdaq/listing requirements, Delaware corporate law, insider trading policies and Regulation FD.
Experience drafting and negotiating corporate or commercial agreements.
Ability to work closely with senior executives and Board members, exercise sound judgment and provide practical, business-oriented legal advice.
Excellent drafting, analytical, project management and communication skills.
Ability to work independently while collaborating closely with the General Counsel and cross-functional teams.
Candidates must be authorized to work in the U.S.

Nice To Haves

Experience with strategic partnerships, licensing, collaborations, M&A or other business development transactions strongly preferred.
Life sciences, biotechnology, or pharmaceutical industry experience preferred.

Responsibilities

Work closely with the General Counsel to draft, review and coordinate SEC filings, including Forms 10-K, 10-Q, 8-K, proxy statements, Section 16 filings, and other public company disclosures.
Advise on corporate governance matters, including Board and committee materials, governance policies, Nasdaq compliance, Delaware corporate law matters, director and officer questionnaires, insider trading policies, Regulation FD and public company best practices.
Support Board and committee processes, including preparation and review of meeting materials, resolutions, minutes, consents and related governance documentation.
Support the Company’s annual meeting and proxy season process, including proxy statement preparation, shareholder meeting logistics and related governance matters.
Partner with Finance, Investor Relations, People/HR, Stock Administration and outside advisors on disclosure, equity compensation, executive compensation and public company compliance matters.
Draft, review and negotiate agreements related to strategic partnerships, business development, licensing, collaborations, M&A, confidentiality, services and other corporate or commercial matters.
Support legal aspects of strategic transactions, including due diligence, transaction documentation, internal approvals and post-signing implementation.
Help manage outside counsel in areas of responsibility.
Provide practical, business-oriented legal advice to cross-functional teams in a fast-paced public company biotechnology environment.
Other duties as assigned.